[ Price : $8.95]
CBER says labeling for GlaxoSmithKlines Rotarix has been updated to include postmarketing trial information suggesting an increase...[ Price : $8.95]
A reading of FDA safety review memos for Avandia illustrates the difficult internal debate the agency constantly faces in its post...[ Price : $8.95]
The House passes H.R. 6130 Strengthening Medicare Anti-Fraud Measures Act that would ban corporate executives from doing business ...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on 510(k) submissions for various types of in vitro diagnostic devices indi...[ Price : $8.95]
Federal Register Notice: FDAs Gastroenterology and Urology Devices Panel will meet 12/2-3 to discuss Oceana Therapeutics Solesta a...[ Price : $8.95]
Federal Register Notice: FDAs Science Advisory Board to the National Center for Toxicological Research will meet 10/19-20 to hear ...[ Price : $8.95]
FDA warns Bay Regional Medical Center of failures of its IRB to protect human subjects.[ Price : $8.95]
DDMAC exceeds last year's totals for issuing Warning and untitled letters sent to pharmaceutical marketers for violating agency ad...